Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Recs

0
Player Avatar pbqstraining (< 20) Submitted: 1/12/2007 10:52:34 PM : Outperform Start Price: $8.56 ENZN Score: -24.17

NICE PIPELINE

Report this Post Reply

Featured Broker Partners


Advertisement